At institutions like Weill Cornell Medicine, AI-powered liquid biopsies are detecting cancer recurrences months or even years earlier than traditional methods, giving patients a critical head start. Beyond early detection, AI is opening doors to precision oncology, including innovations like personalized cancer vaccines tailored to an individual’s unique tumor profile.
While challenges like algorithmic bias and regulatory hurdles must still be addressed, the profound impact of AI in breast cancer care is undeniable. As research advances, AI continues to offer new hope, promising a future where earlier detection and dramatically improved outcomes could become the new standard.